BRIEF-Tenax Therapeutics Announces $8 Mln Registered Direct And Pipe Offerings Priced At-The-Market Under Nasdaq Rules – ReutersBy / July 6, 2020 BRIEF-Tenax Therapeutics Announces $8 Mln Registered Direct And Pipe Offerings Priced At-The-Market Under Nasdaq Rules Reuters Share this:TweetReddit
